Dear friend,
As we recognize Rare Disease Day 2026, I would like to share an update on some of the innovative research and transformative clinical work taking place within the Adrenal Neoplasia Program at the University of Michigan Health Rogel Cancer Center.
We continue to dedicate our time and talent to unraveling the mysteries of rare diseases, inspired by the belief that transformative advances in medicine are possible. Together, we are making a real difference in the field of adrenal cancer and in the lives of those we serve. Thank you for your partnership and commitment.
With gratitude,
Gary Hammer, M.D., Ph.D.
Millie Schembechler Professor of Adrenal Cancer
Director, Endocrine Oncology Program, Rogel Cancer Center
Professor, Internal Medicine
Professor, Molecular and Integrative Physiology
Professor, Cell and Developmental Biology